Alka-Seltzer Original

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 85237-1829
  • Package NDC 85237-1829-1
  • Package NDC 85237-1829-2
  • Package NDC 85237-1829-3
  • Package NDC 85237-1829-4
  • Package NDC 85237-1829-6
  • Package NDC 85237-1829-7
  • Application number M013
  • SPL ID 529c597f-c4b1-98d4-e063-6394a90adba7
  • SPL set ID 3ca80d74-1e8b-49d9-e063-6394a90a4312
  • UNII XF417D3PSL
  • UNII R16CO5Y76E
  • UNII 8MDF5V39QO
  • RxCUI 1536675
  • RxCUI 1536680

What the source publishes

Labeler
Select Consumer Group
Active ingredients
ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE
Form
TABLET, EFFERVESCENT
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
OTC MONOGRAPH DRUG
Product type
HUMAN OTC DRUG
Prescription
Non-prescription

Names this record is found by

Complete source data
us:fda:ndc:85237-1829_529c597f-c4b1-98d4-e063-6394a90adba7
{
  "name": "Alka-Seltzer Original",
  "splId": "529c597f-c4b1-98d4-e063-6394a90adba7",
  "labels": [
    {
      "setId": "3ca80d74-1e8b-49d9-e063-6394a90a4312",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ca80d74-1e8b-49d9-e063-6394a90a4312",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ca80d74-1e8b-49d9-e063-6394a90a4312"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Select Consumer Group",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 POUCH in 1 BLISTER PACK (85237-1829-1)  / 2 TABLET, EFFERVESCENT in 1 POUCH",
      "package_ndc": "85237-1829-1",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20100302"
    },
    {
      "sample": false,
      "description": "2 POUCH in 1 CONTAINER (85237-1829-2)  / 2 TABLET, EFFERVESCENT in 1 POUCH (85237-1829-0)",
      "package_ndc": "85237-1829-2",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20100302"
    },
    {
      "sample": false,
      "description": "20 POUCH in 1 CARTON (85237-1829-3)  / 2 TABLET, EFFERVESCENT in 1 POUCH (85237-1829-0)",
      "package_ndc": "85237-1829-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20100302"
    },
    {
      "sample": false,
      "description": "25 POUCH in 1 CARTON (85237-1829-4)  / 2 TABLET, EFFERVESCENT in 1 POUCH (85237-1829-0)",
      "package_ndc": "85237-1829-4",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20100302"
    },
    {
      "sample": false,
      "description": "50 POUCH in 1 CARTON (85237-1829-6)  / 2 TABLET, EFFERVESCENT in 1 POUCH (85237-1829-0)",
      "package_ndc": "85237-1829-6",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20100302"
    },
    {
      "sample": false,
      "description": "3 POUCH in 1 CONTAINER (85237-1829-7)  / 2 TABLET, EFFERVESCENT in 1 POUCH (85237-1829-0)",
      "package_ndc": "85237-1829-7",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20250604"
    }
  ],
  "productId": "85237-1829_529c597f-c4b1-98d4-e063-6394a90adba7",
  "useDomain": "unknown",
  "dosageForm": "TABLET, EFFERVESCENT",
  "productNdc": "85237-1829",
  "deaSchedule": null,
  "genericName": "ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE",
  "productType": "HUMAN OTC DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ANHYDROUS CITRIC ACID",
      "strength": "1000 mg/1"
    },
    {
      "name": "ASPIRIN",
      "strength": "325 mg/1"
    },
    {
      "name": "SODIUM BICARBONATE",
      "strength": "1916 mg/1"
    }
  ],
  "applicationNumber": "M013",
  "marketingCategory": "OTC MONOGRAPH DRUG",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20100302",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "non-prescription",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175833",
      "N0000175835",
      "N0000175980",
      "N0000008556",
      "N0000175089",
      "N0000000160",
      "N0000008836",
      "M0001335",
      "N0000175722",
      "N0000175578",
      "N0000008832"
    ],
    "upc": [
      "0655708018293",
      "0655708318294",
      "0655708118290",
      "0655708218297"
    ],
    "unii": [
      "XF417D3PSL",
      "R16CO5Y76E",
      "8MDF5V39QO"
    ],
    "rxcui": [
      "1536675",
      "1536680"
    ],
    "spl_set_id": [
      "3ca80d74-1e8b-49d9-e063-6394a90a4312"
    ],
    "pharm_class_cs": [
      "Anti-Inflammatory Agents, Non-Steroidal [CS]"
    ],
    "pharm_class_pe": [
      "Decreased Coagulation Factor Activity [PE]",
      "Decreased Prostaglandin Production [PE]",
      "Decreased Platelet Aggregation [PE]"
    ],
    "pharm_class_epc": [
      "Calculi Dissolution Agent [EPC]",
      "Anti-coagulant [EPC]",
      "Nonsteroidal Anti-inflammatory Drug [EPC]",
      "Platelet Aggregation Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
      "Acidifying Activity [MoA]",
      "Calcium Chelating Activity [MoA]",
      "Cyclooxygenase Inhibitors [MoA]"
    ],
    "manufacturer_name": [
      "Select Consumer Group"
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:85237-1829_529c597f-c4b1-98d4-e063-6394a90adba7"